4.4 Review

Neuroendocrine and metabolic activities of ghrelin gene products

Journal

PEPTIDES
Volume 32, Issue 11, Pages 2323-2332

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.peptides.2011.10.024

Keywords

Acylated ghrelin; Unacylated ghrelin; Obestatin; Liver; Pancreas; Adipose tissue; Neuroendocrine axis

Ask authors/readers for more resources

Acylated ghrelin (AG) is a 28 amino acid gastric peptide a natural ligand for the growth hormone secretagogue (GHS) receptor type la (GHS-R1a), endowed with GH-secreting and orexigenic properties. Besides, ghrelin exerts several peripheral metabolic actions, including modulation of glucose homeostasis and stimulation of adipogenesis. Notably, AG administration causes hyperglycemia in rodents as in humans. Ghrelin pleiotropy is supported by a widespread expression of the ghrelin gene, of GHS-R1 a and other unknown ghrelin binding sites. The existence of alternative receptors for AG, of several natural ligands for GHS-R1a and of acylation-independent ghrelin non-neuroendocrine activities, suggests that there might be a complex 'ghrelin system' not yet completely explored. Moreover, the patho-physiological implications of unacylated ghrelin (UAG), and obestatin (Ob), the other two ghrelin gene-derived peptides, need to be clarified. Within the next few years, we may better understand the 'ghrelin system', where we might envisage clinical applications. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Correction Multidisciplinary Sciences

Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice (vol 10, 732, 2020)

Lucia Recinella, Annalisa Chiavaroli, Giustino Orlando, Claudio Ferrante, Guya Diletta Marconi, Iacopo Gesmundo, Riccarda Granata, Renzhi Cai, Wei Sha, Andrew V. Schally, Luigi Brunetti, Sheila Leone

SCIENTIFIC REPORTS (2020)

Article Multidisciplinary Sciences

Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice

Lucia Recinella, Annalisa Chiavaroli, Valentina Di Valerio, Serena Veschi, Giustino Orlando, Claudio Ferrante, Iacopo Gesmundo, Riccarda Granata, Renzhi Cai, Wei Sha, Andrew Schally, Rossano Lattanzio, Luigi Brunetti, Sheila Leone

Summary: The newly synthesized GHRH antagonists MIA-690 and MR-409 have shown potent pharmacological effects in colon inflammation models, reducing sensitivity to nociceptive stimuli and decreasing the impact of acute and persistent inflammatory stimuli in mice.

SCIENTIFIC REPORTS (2021)

Article Medicine, Research & Experimental

Adipocyte-derived extracellular vesicles regulate survival and function of pancreatic β cells

Iacopo Gesmundo, Barbara Pardini, Eleonora Gargantini, Giacomo Gamba, Giovanni Birolo, Alessandro Fanciulli, Dana Banfi, Noemi Congiusta, Enrica Favaro, Maria Chiara Deregibus, Gabriele Togliatto, Gaia Zocaro, Maria Felice Brizzi, Raul M. Luque, Justo P. Castano, Maria Alessandra Bocchiotti, Simone Arolfo, Stefania Bruno, Rita Nano, Mario Morino, Lorenzo Piemonti, Huy Ong, Giuseppe Matullo, Juan M. Falcon-Perez, Ezio Ghigo, Giovanni Camussi, Riccarda Granata

Summary: Healthy adipocyte-derived EVs are beneficial for beta cell survival and function, while EVs from inflamed adipocytes cause beta cell death and dysfunction. Lean adipocyte-derived EVs have similar beneficial effects, whereas EVs from obese adipose tissue are harmful for beta cells. Differential expression of miRNAs and alterations in signaling pathways and gene expression in recipient beta cells were observed, suggesting that adipocyte-derived EVs may influence beta cell fate and function depending on the physiological and pathological state of adipose tissue.

JCI INSIGHT (2021)

Article Biochemistry & Molecular Biology

Effects of growth hormone-releasing hormone receptor antagonist MIA-602 in mice with emotional disorders: a potential treatment for PTSD

Lucia Recinella, Annalisa Chiavaroli, Giustino Orlando, Claudio Ferrante, Serena Veschi, Alessandro Cama, Guya Diletta Marconi, Francesca Diomede, Iacopo Gesmundo, Riccarda Granata, Renzhi Cai, Wei Sha, Andrew V. Schally, Luigi Brunetti, Sheila Leone

Summary: Anxiety and depression are suggested to increase the risk for PTSD, while GHRH analogs may have therapeutic effects on mood disorders including PTSD by modulating inflammatory and oxidative status and affecting neural pathways.

MOLECULAR PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

Growth hormone-releasing hormone antagonistic analog MIA-690 stimulates food intake in mice

Lucia Recinella, Annalisa Chiavaroli, Giustino Orlando, Claudio Ferrante, Iacopo Gesmundo, Riccarda Granata, Renzhi Cai, Wei Sha, Andrew Schally, Luigi Brunetti, Sheila Leone

Summary: The study found that MIA-690 increased food intake and body weight, while also elevating hypothalamic hormone and neurotransmitter levels and reducing serotonin levels. MR-409 had no significant effects on these markers.

PEPTIDES (2021)

Review Medicine, General & Internal

Erectile Dysfunction in Men with Chronic Obstructive Pulmonary Disease

Lorenzo Marinelli, Fabio Lanfranco, Giovanna Motta, Marco Zavattaro

Summary: Erectile dysfunction is a common issue in men with COPD, caused by various factors including hormonal imbalance, smoking, inflammation, endothelial dysfunction, chronic hypoxia, psychiatric disorders, and medications. This can significantly impact the quality of life for COPD patients, but healthcare providers often do not address sexual health concerns due to patients' reluctance to discuss intimate issues.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Oncology

Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic Signaling

Iacopo Gesmundo, Giuseppina Granato, Antonio C. Fuentes-Fayos, Clara Alvarez, Carlos Dieguez, Maria Chiara Zatelli, Noemi Congiusta, Dana Banfi, Nunzia Prencipe, Sheila Leone, Luigi Brunetti, Justo P. Castano, Raul M. Luque, Renzhi Cai, Wei Sha, Ezio Ghigo, Andrew Schally, Riccarda Granata

Summary: Various studies have shown that GHRH antagonists have inhibitory activities in experimental cancers, and this study found that MIA-602 and MIA-690 have anti-tumor effects in PAs by reducing cell growth and promoting cell death, suggesting they may be considered as new therapeutic options for the treatment of PAs.

CANCERS (2021)

Article Medicine, Research & Experimental

Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice

Lucia Recinella, Annalisa Chiavaroli, Serena Veschi, Valentina Di Valerio, Rossano Lattanzio, Giustino Orlando, Claudio Ferrante, Iacopo Gesmundo, Riccarda Granata, Renzhi Cai, Wei Sha, Andrew V. Schally, Luigi Brunetti, Sheila Leone

Summary: The MIAMI class GHRH antagonist MIA-690 was shown to suppress the progression and growth of colorectal cancer (CRC) by reducing inflammatory and oxidative markers, modulating apoptotic and oncogenic pathways, and improving survival rates in mice. Further research is needed to explore the translation of these findings into clinical applications.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Endocrinology & Metabolism

First baseline data of the Klinefelter ItaliaN Group (KING) cohort: clinical features of adult with Klinefelter syndrome in Italy

D. Pasquali, P. Chiodini, V. Simeon, A. Ferlin, L. Vignozzi, G. Corona, F. Lanfranco, V. Rochira, A. E. Calogero, M. Bonomi, R. Pivonello, G. Balercia, A. Pizzocaro, V. A. Giagulli, P. Salacone, A. Aversa, G. Accardo, M. Maggi, A. Lenzi, A. Isidori, C. Foresta, E. A. Jannini, A. Garolla

Summary: This study is the only national database in Italy that collects clinical and hormonal data of KS patients. Results showed that typical KS patients in Italy are overweight, with small testes, and elevated levels of LH and FSH. Only 25.5% of them are diagnosed with metabolic syndrome. Early detection and timely treatment are essential.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Article Biochemistry & Molecular Biology

Thermomagnetic Resonance Effect of the Extremely Low Frequency Electromagnetic Field on Three-Dimensional Cancer Models

Loredana Bergandi, Umberto Lucia, Giulia Grisolia, Iris Chiara Salaroglio, Iacopo Gesmundo, Riccarda Granata, Romano Borchiellini, Antonio Ponzetto, Francesca Silvagno

Summary: The study developed a thermodynamic biochemical model to select the resonant frequency affecting different types of cancer, and demonstrated its effects in vitro. It investigated the cellular response to ELF electromagnetic wave in 3D cell culture models, finding that ELF-EMF can hinder cancer cell growth and alter metabolism.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma

Iacopo Gesmundo, Francesca Pedrolli, Nicoletta Vitale, Alessia Bertoldo, Giulia Orlando, Dana Banfi, Giuseppina Granato, Ramesh Kasarla, Federico Balzola, Silvia Deaglio, Renzhi Cai, Wei Sha, Mauro Papotti, Ezio Ghigo, Andrew Schally, Riccarda Granata

Summary: This study found that GHRH antagonist MIA-690 enhances the antitumor effect of cisplatin and pemetrexed in pleural mesothelioma by inhibiting proliferative and oncogenic pathways, as well as reducing inflammatory pathways and expression of oxidative, angiogenic, tumorigenic markers, and growth factors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Endocrinology & Metabolism

Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE)

A. M. Isidori, A. Aversa, A. Calogero, A. Ferlin, S. Francavilla, F. Lanfranco, R. Pivonello, V Rochira, G. Corona, M. Maggi

Summary: The diagnosis of adult-onset hypogonadism should be based on clinical and biochemical parameters. Testosterone replacement therapy (TRT) can improve sexual function and body composition, particularly in simpler and aging patients. More research is needed to better understand the long-term efficacy and safety of TRT.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Article Multidisciplinary Sciences

Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice

Marina Boido, Iacopo Gesmundo, Anna Caretto, Francesca Pedrolli, Roberta Schellino, Sheila Leone, Renzhi Cai, Wei Sha, Ezio Ghigo, Andrew V. Schally, Alessandro Vercelli, Riccarda Granata

Summary: The study shows that MR-409 has protective effects on SMN Delta 7 mice, indicating its potential as a promising drug for the treatment of SMA.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Investigation of Brain Activation Patterns Related to the Feminization or Masculinization of Body and Face Images across Genders

Carlo Ceruti, Alessandro Cicerale, Matteo Diano, Mattia Sibona, Caterina Guiot, Giovanna Motta, Chiara Crespi, Anna Gualerzi, Fabio Lanfranco, Mauro Bergui, Federico D'Agata

Summary: Previous studies have shown that there are sex-related differences in brain activation when individuals observe their own bodies and faces. However, a comprehensive paradigm examining multiple aspects of embodied self-identity is lacking. In this study, we used fMRI to investigate the differences in brain activation between males and females during the observation of body silhouettes, morphed faces, and dynamic transformations. Our results revealed differential sexual activations in areas linked to self-identity and the ability to attribute mental states. These findings support previous research and highlight the need for further exploration with a larger sample size.

TOMOGRAPHY (2022)

Article Hematology

Impact of Allogeneic Stem Cell Transplantation on Testicular and Sexual Function

Marco Zavattaro, Francesco Felicetti, Danilo Faraci, Matilde Scaldaferri, Chiara Dellacasa, Alessandro Busca, Margherita Dionisi-Vici, Francesco Cattel, Giovanna Motta, Luisa Giaccone, Ezio Ghigo, Emanuela Arvat, Fabio Lanfranco, Benedetto Bruno, Enrico Brignardello

Summary: This study evaluated the prevalence of testicular dysfunction and sexual impairment in males who underwent allogeneic stem cell transplantation in adulthood. The results showed a higher prevalence of these complications in this patient population compared to the general population, especially in relation to the severity of chronic graft-versus-host disease.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

Article Biochemistry & Molecular Biology

The dual incretin co-agonist tirzepatide increases both insulin secretion and glucose effectiveness in model experiments in mice

Giovanni Pacini, Bo Ahren

Summary: Tirzepatide stimulates both insulin secretion and glucose effectiveness, with stimulation of glucose effectiveness being the prominent process to reduce glucose.

PEPTIDES (2024)

Article Biochemistry & Molecular Biology

Endomorphin-2 analogs with C-terminal esterification display potent antinociceptive effects in the formalin pain test in mice

Si -yu Wang, Yu-zhe Zhang, Xiao-han Liu, Xue-ci Guo, Xiao-fang Wang, Feng-tong Han, Yao Zhang, Chang -lin Wang

Summary: In the formalin pain test, the EM-2 analogs EM-2-Me, EM-2-Et, and EM-2-Bu showed significant analgesic effects with reduced tolerance and gastrointestinal side effects. These effects were mediated through central opioid mechanisms, with EM-2-Me possibly involving dynorphin A release and EM-2-Bu directly activating multiple opioid receptors.

PEPTIDES (2024)